# Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan

> **NCT00969449** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 28 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Naproxen Sodium, (BAY H6689)
- **DRUG:** Naprelan, (BAY H6689)

## Key facts

- **NCT ID:** NCT00969449
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2014-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00969449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00969449, "Pharmacokinetics Study Comparing Naproxen Sodium Extended Release and Naprelan". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00969449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*